Dual inhibition of the PI3K and MAPK pathways enhances nab-paclitaxel/gemcitabine chemotherapy response in preclinical models of pancreatic cancerPublication date: 10 September 2019Source: Cancer Letters, Volume 459Author(s): Niranjan Awasthi, David Kronenberger, Alexis Stefaniak, Md Sazzad Hassan, Urs...